Revisiting the potential of elongation factors as drug targets for pathogenic mycobacteria.

Authors

Mushtaq Ahmad Wani, Shivani Gurjar, Ajay Kumar, Chaaya Iyengar Raje, Prabha Garg

Published in

Drug discovery today. Pages 104823. Oct 03, 2026. Epub Oct 03, 2026.

Abstract

Drug-resistant Mycobacterium tuberculosis and non-tuberculous mycobacteria infections are a threat to global healthcare. The scarcity of therapeutic options highlights the urgent necessity to discover efficacious drug targets and inhibitors. Protein synthesis has been clinically proven to be an excellent target for antibiotic development. Translation involves three well-defined steps: initiation, elongation and termination. The crucial elongation stage utilizes elongation factors (EFs: EF thermo unstable, EF thermo stable and EF G) that facilitate the sequential addition of amino acids. This review provides a perspective on the potential of mycobacterial EFs as innovative targets because of their vital role in translation, trans-translation and other alternative functions.

PMID:
42829047
Bibliographic data and abstract were imported from PubMed on 04 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.